Abivax stock soars after ulcerative colitis drug helps harder-to-treat patients

Abivax stock soars after ulcerative colitis drug helps harder-to-treat patients

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.